Avenue Therapeutics, Inc. Liquidation Value Calculator
Avenue Therapeutics, Inc.
Current Price: N/A
Loading calculator data...
Advanced: All 90 XBRL Tags
Every XBRL tag from SEC EDGAR filings, grouped by financial statement type. total = may include children, fact = independent leaf value.
Balance Sheet
| Tag | Value | Unit | ||
|---|---|---|---|---|
| cash | ||||
| Cash And Cash Equivalents At Carrying Value total CashAndCashEquivalentsAtCarryingValue |
$2.85M | USD | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations total CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations |
$2.85M | USD | ||
| liabilities_current | ||||
| Liabilities Current total LiabilitiesCurrent |
$1.10M | USD | ||
| liabilities_total | ||||
| Liabilities total | $1.10M | USD | ||
| shares_outstanding | ||||
| Common Stock Shares Outstanding total CommonStockSharesOutstanding |
3.2M | shares | ||
Unmapped Tags (84)
| Additional Paid In Capital AdditionalPaidInCapital | $107.32M | USD | ||
| Assets Assets | $2.93M | USD | ||
| Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare | $0 | USD/shares | ||
| Common Stock Shares Authorized CommonStockSharesAuthorized | $200.00M | shares | ||
| Common Stock Shares Issued CommonStockSharesIssued | $3.18M | shares | ||
| Common Stock Value CommonStockValue | $0 | USD | ||
| Deferred Tax Assets Gross DeferredTaxAssetsGross | $34.60M | USD | ||
| Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet | $0 | USD | ||
| Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards | $27.53M | USD | ||
| Deferred Tax Assets Other DeferredTaxAssetsOther | $23,000 | USD | ||
| Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards | $3.04M | USD | ||
| Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance | $34.60M | USD | ||
| Derivative Liabilities Current DerivativeLiabilitiesCurrent | $1,000 | USD | ||
| Investment Income Interest InvestmentIncomeInterest | $121,000 | USD | ||
| Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity | $2.93M | USD | ||
| Minority Interest MinorityInterest | $0 | USD | ||
| Noncash Or Part Noncash Divestiture Amount Of Consideration Received1 NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1 | $1,000 | USD | ||
| Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare | $0 | USD/shares | ||
| Preferred Stock Shares Authorized PreferredStockSharesAuthorized | $2.00M | shares | ||
| Preferred Stock Shares Issued PreferredStockSharesIssued | $250,000 | shares | ||
| Preferred Stock Shares Outstanding PreferredStockSharesOutstanding | $250,000 | shares | ||
| Preferred Stock Value PreferredStockValue | $0 | USD | ||
| Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit | $-105.49M | USD | ||
| Stockholders Equity StockholdersEquity | $1.83M | USD | ||
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest | $1.83M | USD | ||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | $665,000 | USD | ||
| Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense | $665,000 | USD | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect | $261,000 | USD | ||
| Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | $-2,000 | USD | ||
| Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities | $2.09M | USD | ||
| Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities | $-1.83M | USD | ||
| Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock | $2.09M | USD | ||
| Proceeds From Warrant Exercises ProceedsFromWarrantExercises | $0 | USD | ||
| Share Based Compensation ShareBasedCompensation | $665,000 | USD | ||
| Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod | $212 | shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue | $172 | USD/shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber | $235,400 | shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue | $3 | USD/shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod | $416 | shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue | $86 | USD/shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | $0 | USD | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | $256,474 | shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | $10 | USD/shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue | $0 | USD | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber | $93,850 | shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice | $16 | USD/shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue | $0 | USD | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber | $162,624 | shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice | $6 | USD/shares | ||
| Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue | $4,000 | USD | ||
| Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | $1.38M | shares | ||
| Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment | $1.30M | USD | ||
| Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits | $520,000 | USD | ||
| Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals | $38,000 | USD | ||
| Earnings Per Share Basic EarningsPerShareBasic | $-1 | USD/shares | ||
| Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations | $0 | pure | ||
| Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | $0 | pure | ||
| Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | $0 | pure | ||
| Effective Income Tax Rate Reconciliation Disposition Of Business EffectiveIncomeTaxRateReconciliationDispositionOfBusiness | $-1 | pure | ||
| Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | $0 | pure | ||
| General And Administrative Expense GeneralAndAdministrativeExpense | $3.65M | USD | ||
| Income Tax Expense Benefit IncomeTaxExpenseBenefit | $2,000 | USD | ||
| Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | $-870,000 | USD | ||
| Income Tax Reconciliation Disposition Of Business IncomeTaxReconciliationDispositionOfBusiness | $1.52M | USD | ||
| Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | $615,000 | USD | ||
| Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes | $2,000 | USD | ||
| Net Income Loss NetIncomeLoss | $-2.91M | USD | ||
| Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest | $-38,000 | USD | ||
| Operating Expenses OperatingExpenses | $4.49M | USD | ||
| Operating Income Loss OperatingIncomeLoss | $-3.08M | USD | ||
| Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent | $76,000 | USD | ||
| Research And Development Expense ResearchAndDevelopmentExpense | $1.04M | USD | ||
| Revenues Revenues | $1.40M | USD | ||
| Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued | $0 | USD | ||
| Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense | $0 | USD | ||
| Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 | $11 | USD/shares | ||
| Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding | $772,741 | shares | ||
| Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount | $203,000 | USD | ||
| Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants | $-15,000 | USD | ||
| Number Of Operating Segments NumberOfOperatingSegments | $1 | pure | ||
| Number Of Reportable Segments NumberOfReportableSegments | $1 | pure | ||
| Profit Loss ProfitLoss | $-2.95M | USD | ||
| Stock Issued1 StockIssued1 | $55,000 | USD | ||
| Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues | $55,000 | USD |
Showing balance sheet tags only. Liquidation analysis uses balance sheet data.